Gabi Hanna MD.
Gabi joined Duke University at 2006 in Surgerical Oncology department, in 2008 he became Sr. Research Associate at Radiation Oncology Department Microcirculation laboratory. He is currently lead and manage antiangiogenic therapy project sponsored by Glaxosmithkline and Duke Cancer Center.
Dr. Hanna is a borad member of Duke Medical Center IRB. has responsibility for the review of research involving human subjects for the Duke University Schools of Medicine.